HIF inhibitors and use thereof
US10881656B2 · kind B2 · utility
0Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2017 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Feb 14, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D335/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to HIF inhibitors and methods of preventing cell proliferation, reducing inflammation, and treating an angiogenic disease or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.